title: Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3.
abstract: IFN regulatory factor 3 (IRF3), a constitutively expressed protein localizing largely to the cytoplasm, is a primary effector of the innate immune response. Infection can trigger the phosphorylation, dimerization, and nuclear translocation of IRF3, where the factor stimulates the expression and release of IFN. In this study, we determined that the rotavirus gene 5 product, nonstructural protein 1 (NSP1), interacts with IRF3 in the infected cell. To understand the importance of the interaction, we compared IRF3 activation by rotaviruses expressing wild-type and C-truncated forms of NSP1. The analysis showed that IRF3 underwent dimerization and nuclear translocation and stimulated IFN promoter activity in infected cells expressing truncated NSP1. In contrast, infected cells expressing wild-type NSP1 were characterized by the rapid degradation of IRF3 during the replication cycle, severe decreases in IRF3 dimerization and nuclear translocation, and lack of IFN promoter activity. The implication of these results, that wild-type NSP1 is an antagonist of the IFN-signaling pathway, was confirmed in transient expression assays, which showed that wild-type NSP1, but not the C-truncated protein, induced the degradation of IRF3 fusion proteins. Related experiments indicated that NSP1 mediates IRF3 degradation through a proteasome-dependent pathway. The critical role of NSP1 in promoting cell-to-cell spread of rotavirus was demonstrated by using gene 5-specific short interfering RNAs in plaque assays. Although several viruses have been described that subvert the innate immune response by preventing IRF3 activation, rotavirus is identified as one that accomplishes this task by inducing the degradation of IRF3.
authors.affiliation: Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
authors.forename: Mario
authors.initials: M
authors.lastname: Barro
authors.forename: John T
authors.initials: JT
authors.lastname: Patton
mesh_terms: D000818:Animals; D018938:Caco-2 Cells; D002467:Cell Nucleus / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D019281:Dimerization; D006801:Humans; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology*; D050838:Interferon Regulatory Factor-3; D011401:Promoter Regions, Genetic; D061988:Proteasome Inhibitors; D021381:Protein Transport / Q000502:physiology; D012401:Rotavirus / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D012400:Rotavirus Infections / Q000276:immunology* / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism*; D020798:Two-Hybrid System Techniques; D017361:Viral Nonstructural Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*
chemical_list: D004268:DNA-Binding Proteins; C494232:IRF3 protein, human; D050838:Interferon Regulatory Factor-3; D061988:Proteasome Inhibitors; D014157:Transcription Factors; D017361:Viral Nonstructural Proteins
references.citation: Gastroenterology. 1997 Jul;113(1):81-9
references.pmid: 9207265
references.citation: J Biochem. 1996 Jul;120(1):160-9
references.pmid: 8864859
references.citation: Genes Dev. 1998 Jul 1;12(13):2061-72
references.pmid: 9649509
references.citation: J Interferon Cytokine Res. 1999 Jan;19(1):1-13
references.pmid: 10048763
references.citation: J Virol. 1996 Jun;70(6):4125-30
references.pmid: 8648754
references.citation: Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
references.pmid: 10725408
references.citation: J Virol. 2000 Sep;74(17):7989-96
references.pmid: 10933707
references.citation: J Virol. 2001 Mar;75(5):2076-86
references.pmid: 11160712
references.citation: Genes Cells. 2001 Apr;6(4):375-88
references.pmid: 11318879
references.citation: Novartis Found Symp. 2001;238:153-71; discussion 171-9
references.pmid: 11444025
references.citation: J Virol. 2002 Mar;76(5):2180-91
references.pmid: 11836395
references.citation: J Virol. 2002 Apr;76(8):3659-69
references.pmid: 11907205
references.citation: J Virol. 2002 May;76(9):4467-82
references.pmid: 11932413
references.citation: Virology. 2002 May 10;296(2):204-11
references.pmid: 12069519
references.citation: J Virol. 2002 Sep;76(18):9545-50
references.pmid: 12186937
references.citation: Science. 2003 May 16;300(5622):1148-51
references.pmid: 12702806
references.citation: Science. 2003 May 16;300(5622):1145-8
references.pmid: 12702807
references.citation: J Virol. 2003 Jul;77(14):7945-56
references.pmid: 12829834
references.citation: J Virol. 2004 Apr;78(8):4363-9
references.pmid: 15047850
references.citation: J Virol. 2004 Jul;78(14):7737-47
references.pmid: 15220448
references.citation: J Virol. 2004 Jul;78(14):7763-74
references.pmid: 15220450
references.citation: EMBO J. 2004 Oct 13;23(20):4072-81
references.pmid: 15372078
references.citation: J Virol. 1993 May;67(5):2448-55
references.pmid: 8386262
references.citation: J Virol. 1994 Jun;68(6):3990-4000
references.pmid: 8189533
references.citation: Virology. 1994 Aug 15;203(1):178-83
references.pmid: 8030275
references.citation: Proc Natl Acad Sci U S A. 1995 Dec 5;92(25):11657-61
references.pmid: 8524823
references.citation: Mol Cell Biol. 1998 May;18(5):2986-96
references.pmid: 9566918